Gsto2 | glutathione S-transferase omega 2
Physiological systems
18 / 24 physiological systems tested
4 Significantly impacted by the knock-out
Integument Growth/size/body region Skeleton Cardiovascular system
14 No significant impact
6 Not tested
Data collections
Gene metrics:4Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
increased bone mineral density | 1 supporting dataset | Gsto2tm2a(KOMP)Wtsi | homozygote | Early adult | 8.38x10-6 | ||
increased heart weight | 1 supporting dataset | Gsto2tm2a(KOMP)Wtsi | homozygote | Early adult | 7.3x10-6 | ||
abnormal vibrissa morphology | 1 supporting dataset | Gsto2tm2a(KOMP)Wtsi | homozygote | Early adult | 6.98x10-5 | ||
increased bone mineral content | 1 supporting dataset | Gsto2tm2a(KOMP)Wtsi | homozygote | Early adult | 2.75x10-6 |
| | | | | | | | | |
Human diseases caused by Gsto2 mutations
The analysis uses data from IMPC, along with published data on other mouse mutants, in comparison to human disease reports in OMIM, Orphanet, and DECIPHER.
Phenotype comparisons summarize the similarity of mouse phenotypes with human disease phenotypes.
External links
No external links available for Gsto2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Gsto2tm1e(KOMP)Wtsi | Targeted, non-conditional allele | | ES Cell |
Gsto2tm2a(KOMP)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell mouse |
Gsto2tm2e(KOMP)Wtsi | Targeted, non-conditional allele | | ES Cell |